Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 1
  • 6
  • 10
  • 1
  • 10

Found 10 Weight Loss trials

A listing of Weight Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 STABLE Weight Loss Study (Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects)
18 years - 70 years
All genders
Phase 4
The STABLE Weight Loss study is a 72-week research study that is designed to help participants lose weight. All participants will receive lifestyle modification (diet and exercise) counseling, and will be prescribed the FDA-approved weight loss medication, semaglutide, or placebo (an inactive saline solution). The purpose of the research is to test …
 Food Rx: Food Supplementation Interventions to Improve Weight Loss for Adults With Food Insecurity and Obesity
18 years - 100 years
All genders
Phase 2
The purpose of this intervention research project is to conduct a randomized controlled trial in adults with obesity and food insecurity to assess whether behavioral weight loss treatment and providing food or resources for food can improve weight loss, diet quality, and perceived physical and mental health in individuals with obesity and food insecurity. …
 Research Study on Whether a Combination of 2 Medicines  Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non alcoholic steatohepatitis (NASH). NNC0194-0499 is a new medicine which works in the liver. Semaglutide is a well-known medicine, which is already used by doctors to …
99 years or below
All genders
The success of behavioral weight loss is undermined by weight regain. Participants will be assessed at baseline and reassessed if they attain a minimum 7% weight loss (month 0) and undergo follow-up assessments 4 and 12-months later. Changes in physiological measures of metabolism and appetite during weight loss will be …
 UPCC 15518 / ANAM-17-21: A Phase 3  Randomized  Double-Blind  Placebo-Controlled  Multicenter Study to Evaluate the Efficacy and Safety of anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
18 years - 99 years
All genders
Phase 3
The main purpose of this study is to learn more about how well the experimental drug, anamorelin hydrochloride (HCl), works to prevent weight loss and anorexia in patients with advanced Non-Small Cell Lung Cancer.
18 years - 99 years
All genders
The aim of the pilot study is to demonstrate feasibility and tolerability of semaglutide in patients with obesity and advanced ILD. 
22 years - 65 years
All genders
Interventional
This is an early feasibility study looking at the safety, feasibility, and potential benefit of a medical device, called the NeuroPace RNS System, for people suffering from obesity, with uncontrolled eating habits.
 TRILOGY
18 years - 65 years
All genders
The target population are patients at Penn Medicine undergoing elective bariatric surgery; and are additionally participating in POW-R study ( Protocol #843280) Patients will be recruited to undergo liver wedge and visceral adipose tissue biopsy and provide blood samples. Liver samples will be processed for RNA, metabolomics, and biochemical and …
 Diet Interventions in Psoriatic Arthritis
18 years - 99 years
All genders
Observational
In this randomized controlled pilot trial, we will test whether a Mediterranean diet (focused on healthy food intake) or a low calorie/low fat (LC/LF) diet (aiming for weight reduction) improves disease outcomes compared to no dietary intervention among patients with PsA.
18 years or above
All genders
Observational
This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The Investigators plan to …